Intellectual Property

  • February 12, 2026

    Colo. Builder Says Ex-Assistant Stole Trade Secrets

    The former executive assistant of a high-end Denver homebuilder misappropriated confidential vendor and customer information to pursue a competing business in violation of federal and state trade secrets laws, the construction company told a Colorado federal court.

  • February 12, 2026

    Inventor Says Claims Against Baker Botts Atty Should Remain

    Inventor Leigh M. Rothschild and Analytical Technologies LLC are taking issue with a Florida federal judge recommending tossing some claims in their lawsuit alleging a patent attorney defamed him, arguing Rothschild's words should be considered commercial speech.

  • February 12, 2026

    Astellas Gets $120M From Zydus In Bladder Drug Deal

    Generic-drug maker Zydus Pharmaceuticals has inked a $120 million deal to end a lawsuit accusing it of infringing Astellas Pharma Inc. patents covering bladder drug Myrbetriq, just two days after Lupin Pharmaceuticals made a similar deal.

  • February 12, 2026

    IP Firms Are Navigating AI Era With Range Of Guardrails

    Intellectual property law firms are taking various approaches to implementing artificial intelligence into their professional routines, with some developing their own tools, others limiting what external AI platforms that lawyers can access and one firm saying it has banned attorneys from using AI to draft legal briefs.

  • February 12, 2026

    InterDigital Says TCL, Hisense TVs Infringe Video Patents

    American firm InterDigital Inc. accused Chinese TV manufacturers Hisense Co. Ltd. and TCL Technology Group Corp. of selling televisions that infringe its video coding patents in separate federal district court suits as part of a worldwide litigation effort against the two companies.

  • February 12, 2026

    Regeneron, Samsung Bioepis Settle Eye Med Patent Claims

    Regeneron Pharmaceuticals Inc. and Samsung Bioepis Co. Ltd. have told a West Virginia federal court they reached an agreement to end patent infringement claims brought by Regeneron over a biosimilar of its eye medication Eylea.

  • February 12, 2026

    Intellectual Property Group Of The Year: Kirkland

    Kirkland & Ellis LLP attorneys notched landmark victories across copyright, patents and trade secrets, including the first U.S. decision to address whether training artificial intelligence systems with copyrighted content qualifies as fair use, earning the firm a spot among the 2025 Law360 Intellectual Property Groups of the Year.

  • February 12, 2026

    Chinese Co. Lacks Standing To Sue Hose Maker, Judge Says

    A Delaware federal judge has thrown out a suit from a Chinese company that wanted a declaration that its products didn't infringe a hose maker's patents after certain hoses were delisted on Amazon, saying the company lacked standing to sue.

  • February 11, 2026

    GoDaddy Challenges $170M Loss, Patent Owner Wants $370M

    GoDaddy is looking to nix its $170 million verdict loss in Express Mobile's lawsuit that accused the website hosting platform of willfully infringing patents related to creating websites while Express Mobile urged a Delaware federal court to increase its damages to $370 million, according to newly unsealed court filings.

  • February 11, 2026

    Fed. Circ. Backs $85M Patent Antitrust Verdict Against Ingevity

    The Federal Circuit on Wednesday declined to disturb a Delaware jury's $85 million antitrust verdict against Ingevity over it tying patent licenses to purchases of its automobile carbon filtering technology, rejecting the company's arguments that it was entitled to a certain statutory patent misuse defense.

  • February 11, 2026

    Design Patent Dissent Highlights Frustration Over Subjectivity

    Federal Circuit Judge Kimberly Moore's impassioned dissent to the court throwing out a design patent infringement suit captured how difficult it can be to frame comparisons, from a legal standard and based on differences in how people perceive the world, attorneys say.

  • February 11, 2026

    Judge Seeks Clarity On OpenAI's 'Project Giraffe' For IP Suit

    A New York federal magistrate judge on Wednesday ordered OpenAI to respond to questions about its "Project Giraffe," which plaintiffs suing over the company's use of copyrighted material in ChatGPT training describe as an effort to identify and block infringing outputs.

  • February 11, 2026

    Justices Urged To Restore $181M Verdict Against AT&T, Nokia

    Finesse Wireless LLC has asked the U.S. Supreme Court to take up its challenge to the Federal Circuit's decision wiping out a $181 million verdict against AT&T and Nokia, saying it's part of a long trend of the circuit court not respecting jury verdicts.

  • February 11, 2026

    CoStar Digs In On Quinn Emanuel DQ Bid In CREXi IP Suit

    CoStar doubled down on its efforts to disqualify Quinn Emanuel Urquhart & Sullivan LLP counsel from representing rival CREXi amid copyright infringement litigation in California federal court, reiterating that it's not bound by a conflict waiver signed by a company CoStar later acquired.

  • February 11, 2026

    Blockbuster's TM Legacy Tested By Dispute Over Deer Feed

    Once a titan in U.S. retail, the Blockbuster brand is embroiled in an unexpected trademark battle with a Mississippi-based animal feed company that it accuses of trying to exploit the legacy of the once-ubiquitous video rental chain.

  • February 11, 2026

    9th Circ. Mulls DMCA Claim Against Microsoft And OpenAI

    A group of software developers Wednesday urged the Ninth Circuit to revive their claim that Microsoft, GitHub and OpenAI violated the Digital Millennium Copyright Act by stripping copyright management information from the developers' open source code, which the companies then used to develop the artificial intelligence tools for Microsoft's Copilot software.

  • February 11, 2026

    Calif. Atty Wins $25K Fee Sanction Over AI Errors

    A California federal court has ordered $25,000 in fee sanctions for a litigator representing a mobile app platform in a copyright and contract suit as reimbursement for work he said went into responding to an error-ridden motion and further resulting motion practice.

  • February 11, 2026

    Lighting Co. Signify Nets $411K Verdict In Patent Case

    A Nevada federal jury found that lighting company Lepro owes nearly $411,000 in a suit brought by rival Signify over LED technology patents after finding the remaining three patents before the jury were infringed.

  • February 11, 2026

    Estee Lauder Hits Walmart With TM Suit Alleging Copycats

    Estee Lauder hit Walmart with a trademark infringement suit in California federal court Monday, accusing it of hawking copycat versions of its luxury personal care products, cosmetics and fragrance collections sold under popular brands including Clinique, La Mer and Tom Ford. 

  • February 11, 2026

    Squires Spurns 16 Petitions, Grants 6 In Latest Bulk Order

    U.S. Patent and Trademark Office Director John Squires' latest summary decision instituted six petitions for America Invents Act patent challenges and denied 16 others, bringing his total of rejected petitions to 266.

  • February 11, 2026

    Miami World Cup Counsel Share Look At Prep Work, Impact

    Counsel representing the FIFA World Cup's Miami Host Committee gave Law360 an inside look at their multifaceted work preparing for the upcoming event, which organizers say could have the economic impact of multiple Super Bowls.

  • February 11, 2026

    Supreme Court Sets April Argument For 'Skinny Label' Case

    The U.S. Supreme Court has set an April 29 date for oral arguments in Hikma Pharmaceutical Inc.'s appeal of a decision that revived a patent case over its "skinny label" on a generic heart drug.

  • February 11, 2026

    7th Circ. Mulls Expiration Date Of Teva, Eli Lilly Patent Deal

    Seventh Circuit judges Wednesday pressed counsel for Teva Pharmaceuticals USA Inc. to address how long a settlement under which Eli Lilly & Co. agreed not to block the approval and marketing of Teva's generic version of its osteoporosis drug Forteo could reasonably remain in effect, given Teva's drug wasn't ready for market until years after the underlying patent dispute.

  • February 11, 2026

    Shkreli Can't Add Wu-Tang Members To Fight With Crypto Co.

    "Pharma Bro" Martin Shkreli can't drag two members of the Wu-Tang Clan hip-hop group into a suit brought by a crypto firm that claims Shkreli improperly retained copies of an album that it bought the rights to, a New York federal judge ruled on Wednesday.

  • February 11, 2026

    MrBeast, Ex-IT Worker Near Deal In Trade Secret Theft Dispute

    YouTube star MrBeast's media company has told a North Carolina federal judge it has reached a settlement in principle to resolve its lawsuit accusing a former IT contractor of downloading thousands of confidential company documents ahead of his firing and leaving behind hidden cameras throughout the company's offices.

Expert Analysis

  • Series

    Law School's Missed Lessons: Educating Your Community

    Author Photo

    Nearly two decades prosecuting scammers and elder fraud taught me that proactively educating the public about the risks they face and the rights they possess is essential to building trust within our communities, empowering otherwise vulnerable citizens and preventing wrongdoers from gaining a foothold, says Roger Handberg at GrayRobinson.

  • Adapting To USPTO's Reduction Of Examiner Interview Time

    Author Photo

    Reported changes to the U.S. Patent and Trademark Office's examiner performance appraisal plan will likely make interviews scarcer throughout the application process, potentially influencing patent allowance rates and increasing the importance of approaching each interview with a clear agenda and well-defined goals, say attorneys at Polsinelli.

  • What To Know About Interim Licenses In Global FRAND Cases

    Author Photo

    Recent U.K. court decisions have shaped a framework for interim licenses in global standard-essential patent disputes, under which parties can benefit from operating on temporary terms while a court determines the final fair, reasonable and nondiscriminatory terms — but the future of this developing remedy is in doubt, say attorneys at Fish & Richardson.

  • 5 Crisis Lawyering Skills For An Age Of Uncertainty

    Author Photo

    As attorneys increasingly face unprecedented and pervasive situations — from prosecutions of law enforcement officials to executive orders targeting law firms — they must develop several essential competencies of effective crisis lawyering, says Ray Brescia at Albany Law School.

  • Anticipating FTC's Shift On Unfair Competition Enforcement

    Author Photo

    As the Federal Trade Commission signals that it will continue to challenge unfair or deceptive acts and practices under Section 5 of the FTC Act, but with higher evidentiary standards, attorneys counseling healthcare, technology, energy or pharmaceuticals clients should note several practice tips, says Thomas Stratmann at George Mason University.

  • Opinion

    It's Time For The Judiciary To Fix Its Cybersecurity Problem

    Author Photo

    After recent reports that hackers have once again infiltrated federal courts’ electronic case management systems, the judiciary should strengthen its cybersecurity practices in line with executive branch standards, outlining clear roles and responsibilities for execution, says Ilona Cohen at HackerOne.

  • Identifying The Sources And Impacts Of Juror Contamination

    Author Photo

    Jury contamination can be pervasive, so it is important that trial teams be able to spot its sources and take specific mitigation steps, says consultant Clint Townson.

  • Parody Defendants Are Finding Success Post-Jack Daniel's

    Author Photo

    Recent decisions demonstrate that, although the U.S. Supreme Court's decision in Jack Daniel's v. VIP Products did benefit trademark plaintiffs by significantly limiting the First Amendment expressive use defense, courts also now appear to be less likely to find a parodic work likely to cause confusion, says Andrew Michaels at University of Houston Law Center.

  • Series

    Writing Novels Makes Me A Better Lawyer

    Author Photo

    Writing my debut novel taught me to appreciate the value of critique and to never give up, no matter how long or tedious the journey, providing me with valuable skills that I now emphasize in my practice, says Daniel Buzzetta at BakerHostetler.

  • Trader Joe's Ruling Highlights Trademark Infringement Trends

    Author Photo

    The Ninth Circuit's recent decision in Trader Joe's Co. v. Trader Joe's United explores the legal boundaries between a union's right to advocate for workers and the protection of a brand's intellectual property, and illustrates a growing trend of courts disfavoring early dismissal of trademark infringement claims in the context of expressive speech, say attorneys at Mitchell Silberberg.

  • SDNY OpenAI Order Clarifies Preservation Standards For AI

    Author Photo

    The Southern District of New York’s recent order in the OpenAI copyright infringement litigation, denying discovery of The New York Times' artificial intelligence technology use, clarifies that traditional preservation benchmarks apply to AI content, relieving organizations from using a “keep everything” approach, says Philip Favro at Favro Law.

  • Addressing Legal Risks Of AI In The Homebuilding Industry

    Author Photo

    Artificial intelligence is transforming the homebuilding industry, but the legal challenges posed by its adoption spread across many areas, including contractual liability and intellectual property issues, so builders should adopt strategies to mitigate the risks and position themselves for success, says Philip Stein at Bilzin Sumberg.

  • Trends In Post-Grant Practice Since USPTO Denial Guidance

    Author Photo

    Six months after the U.S. Patent and Trademark Office updated its guidance on discretionary denial of inter partes review and post-grant review, noteworthy trends in denial statistics have emerged, warranting a reassessment of strategies for parallel proceedings, says Andrew Ramos at Bayes.

  • USPTO Under Squires: A Look At The First Month

    Author Photo

    New U.S. Patent and Trademark Office Director John Squires' opening acts — substantive and symbolic — signal a posture that is more welcoming to technological improvements and focused on rebalancing the office's gatekeeping role, say attorneys at Seyfarth.

  • 3rd Circ. Ruling Forces A Shift In Employer CFAA Probes

    Author Photo

    The Third Circuit's recent ruling in NRA Group v. Durenleau, finding that "unauthorized access" requires bypassing technical barriers rather than simply violating company policies, is forcing employers to recalibrate insider misconduct investigations and turn to contractual, trade secret and state-level claims, say attorneys at Sidley.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.